<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Microbiology and epidemiology of Cryptococcus neoformans infection</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Microbiology and epidemiology of Cryptococcus neoformans infection</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Microbiology and epidemiology of Cryptococcus neoformans infection</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Gary M Cox, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John R Perfect, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Carol A Kauffman, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Milana Bogorodskaya, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Dec 04, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Cryptococcosis is an invasive fungal infection due to <em>Cryptococcus neoformans </em>or <em>Cryptococcus gattii</em> that has become increasingly prevalent in immunocompromised patients. <em>C. neoformans </em>is the principal pathogenic member of the genus and has a worldwide distribution. </p><p>The microbiology and epidemiology of Cryptococcus neoformans will be reviewed here. Topic reviews that discuss the microbiology and epidemiology of <em>C. gattii</em>, as well as the clinical manifestations, diagnosis, and treatment of <em>C. neoformans</em> infection, are found elsewhere. </p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/16624.html" rel="external">"Cryptococcus gattii infection: Microbiology, epidemiology, and pathogenesis"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/3757.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in patients with HIV"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2447.html" rel="external">"Clinical manifestations and diagnosis of Cryptococcus neoformans meningoencephalitis in patients without HIV"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2443.html" rel="external">"Cryptococcus neoformans: Treatment of meningoencephalitis and disseminated infection in patients without HIV"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/83651.html" rel="external">"Cryptococcus neoformans meningoencephalitis in persons with HIV: Treatment and prevention"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/2421.html" rel="external">"Cryptococcus neoformans infection outside the central nervous system"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/d/html/85376.html" rel="external">"Clinical management and monitoring during antifungal therapy for cryptococcal meningoencephalitis in persons with HIV"</a>.)</p><p></p><p class="headingAnchor" id="H2"><span class="h1">MICROBIOLOGY</span></p><p class="headingAnchor" id="H3"><span class="h2">Taxonomy</span><span class="headingEndMark"> — </span>Pathogenic cryptococci are basidiomycetous, encapsulated yeasts that can be subclassified into four serotypes and two species. <em>Cryptococcus neoformans</em> is further subdivided into two varieties. The serotypes are based upon capsular agglutination reactions and are designated A, B, C, or D. </p><p>The cryptococcal taxonomic nomenclature continues to rapidly evolve with more strains sequenced. It is presently reasonable from a clinical perspective to divide <em>Cryptococcus </em>into two species complexes: <em>Cryptococcus neoformans</em> (Serotype A,D) and <em>Cryptococcus</em> <em>gattii</em> (Serotype B,C) [<a href="#rid1">1</a>]. However, Serotype A strains are considered <em>C. neoformans</em> var. grubii and divided into four molecular types: VNI, VNII, VNBI, and VNBII. Serotype D is classified as <em>C</em>. <em>neoformans</em> var neoformans or <em>C</em>. <em>deneoformans</em>. The C. gattii species complex (serotype B,C) has now been divided into five to six subspecies or lineages [<a href="#rid1">1-3</a>] without apparent clinical relevance yet for these subspecies/lineages.</p><p>A detailed discussion of <em>C. gattii</em> is found elsewhere. (See  <a class="medical medical_review" href="/d/html/16624.html" rel="external">"Cryptococcus gattii infection: Microbiology, epidemiology, and pathogenesis", section on 'Molecular types'</a>.)</p><p class="headingAnchor" id="H4"><span class="h2">Life cycle</span><span class="headingEndMark"> — </span>The life cycle of <em>C. neoformans</em> involves asexual and sexual forms. The asexual form exists as yeast and reproduces by budding. These haploid, unicellular yeasts are the only forms of <em>C. neoformans</em> that have been recovered from human infections.</p><p>The sexual state (also known in mycology as the "perfect state") of <em>C. neoformans</em> has been observed only in the laboratory. Sexual structures have not been found in nature, but apparent sexual recombination events have been detected [<a href="#rid4">4</a>]. The yeast forms can exist in one of two mating types designated "a" and alpha. Coculture of yeast of each mating type on certain agars can result in conjugation that produces the sexual state. Conjugation between the alpha and "a" types results in the formation of the teleomorph, which consists of dikaryotic hyphae that contain clamp connections.</p><p>Some of the hyphae develop into specialized structures called basidia. Meiosis occurs at the terminal portion of the basidia resulting in formation of uninucleate basidiospores. These spores are initially unencapsulated but can quickly develop capsules when released from the basidia. Budding may begin after encapsulation, thereby completing the life cycle.</p><p class="headingAnchor" id="H5"><span class="h2">Growth and identification</span><span class="headingEndMark"> — </span><em>C. neoformans</em> produce white mucoid colonies on a variety of agars that usually become visible to the naked eye within 48 hours  (<a class="graphic graphic_picture graphicRef75483" href="/d/graphic/75483.html" rel="external">picture 1</a>). The identification of <em>C. neoformans</em> in the clinical laboratory begins with isolation of a urease-positive, encapsulated yeast. <em>C. neoformans</em> can be distinguished from <em>C. gattii</em> by growth features on canavanine-glycine-bromothymol blue (CGB) agar or by molecular tests. (See  <a class="medical medical_review" href="/d/html/85842.html" rel="external">"Cryptococcus gattii infection: Clinical features and diagnosis", section on 'Culture and histopathology'</a> and  <a class="medical medical_review" href="/d/html/85842.html" rel="external">"Cryptococcus gattii infection: Clinical features and diagnosis", section on 'Molecular tests'</a>.)</p><p>Further confirmation can be achieved with biochemical tests contained in commercial kits and by detection of the enzyme phenol oxidase, which is solely produced by <em>C. neoformans</em> and <em>C. gattii</em>. However, most clinical microbiology laboratories do not stock the expensive agars required for detecting this enzyme. Most laboratories use a variety of sugar fermentations contained in commercial kits to identify the organism. In some clinical laboratories, these species can be rapidly and efficiently identified by matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF) [<a href="#rid5">5-7</a>].</p><p class="headingAnchor" id="H6"><span class="h2">Histologic identification</span><span class="headingEndMark"> — </span>The yeast form of <em>Cryptococcus</em> can be identified in histopathologic specimens using methenamine silver stain. Mucicarmine stain highlights both the yeast form and the capsule and is specific for <em>Cryptococcus</em>  (<a class="graphic graphic_picture graphicRef82930" href="/d/graphic/82930.html" rel="external">picture 2</a>). The Fontana-Masson stain reveals melanin contained in the yeast.</p><p class="headingAnchor" id="H7"><span class="h2">Capsule</span><span class="headingEndMark"> — </span>The polysaccharide capsule surrounding <em>C. neoformans</em> can be visualized in a suspension of India ink when examined under the microscope. The capsule appears as a clear area amidst the ink particles  (<a class="graphic graphic_picture graphicRef63752" href="/d/graphic/63752.html" rel="external">picture 3</a>). The thickness of the capsule can vary but can comprise more than 50 percent of the diameter of the yeast cell in some isolates.</p><p>The capsule has antiphagocytic properties and is an important virulence determinant [<a href="#rid8">8</a>]. Mutant cryptococci that are either hypocapsular or acapsular are less virulent in animal models than encapsulated strains and undergo increased phagocytosis by white blood cells in vitro [<a href="#rid9">9,10</a>].</p><p><em>C. neoformans</em> strains can undergo phenotypic switching with prolonged in vitro passage (prolonged growth on standard fungal media), and one group has demonstrated this phenomenon in vivo in mice, resulting in increased virulence and death [<a href="#rid11">11</a>]. In this model, phenotypic switching led to changes in the polysaccharide capsule, which further reduced alveolar macrophage phagocytosis and promoted a more vigorous inflammatory reaction that was destructive to lung tissue.</p><p>The capsule is composed of a polysaccharide scaffold onto which are attached proteins and enzymes. The vast majority of the polysaccharide is glucuronoxylomannan (GXM), and this is shed by the organism during the course of infection and can be detected in fluid and tissue. The current serologic assays for cryptococcal antigen that are used for diagnosis detect the capsular polysaccharides. (See  <a class="medical medical_review" href="/d/html/3757.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in patients with HIV", section on 'Cryptococcal antigen (CrAg)'</a> and  <a class="medical medical_review" href="/d/html/2447.html" rel="external">"Clinical manifestations and diagnosis of Cryptococcus neoformans meningoencephalitis in patients without HIV", section on 'Cryptococcal antigen'</a>.)</p><p class="headingAnchor" id="H8"><span class="h2">Melanin production</span><span class="headingEndMark"> — </span>The presence of the enzyme phenol oxidase in <em>C. neoformans</em> and C. <em>gattii </em>is unique among members of the genus. This enzyme catalyzes one step in the conversion of phenolic compounds to melanin. A wide variety of phenolic substrates can be utilized by the cryptococcal phenol oxidase, including catecholamines, such as dopamine and epinephrine.</p><p>The phenol oxidase enzyme may be an important virulence factor for cryptococcal infection. Cryptococcal mutants lacking phenol oxidase activity are avirulent in animal models and are more susceptible to antibody-mediated phagocytosis [<a href="#rid12">12</a>].</p><p>Phenol oxidase may promote virulence via one of several possible mechanisms:</p><p class="bulletIndent1"><span class="glyph">●</span>High level of dopamine in the central nervous system may serve as a substrate for melanin production by the organism [<a href="#rid13">13</a>]. In addition, the ability to degrade catecholamines may protect the yeast from toxic effects of catecholamines in the central nervous system [<a href="#rid14">14</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Melanin is an antioxidant that is produced and accumulates in the cell wall where it may protect against attack by immune effector cells and oxidative products [<a href="#rid15">15</a>].</p><p></p><p class="headingAnchor" id="H1064756847"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span><em>C. neoformans </em>is the principal pathogenic member of the genus and has a worldwide distribution. The majority of patients with cryptococcosis are immunocompromised due to one of the following conditions (listed in order of decreasing frequency):</p><p class="bulletIndent1"><span class="glyph">●</span>AIDS</p><p class="bulletIndent1"><span class="glyph">●</span>Prolonged treatment with glucocorticoids</p><p class="bulletIndent1"><span class="glyph">●</span>Organ transplantation</p><p class="bulletIndent1"><span class="glyph">●</span>Malignancy</p><p class="bulletIndent1"><span class="glyph">●</span>Liver disease [<a href="#rid16">16</a>]</p><p class="bulletIndent1"><span class="glyph">●</span>Sarcoidosis [<a href="#rid17">17</a>]</p><p></p><p>The serotypes or genotypes of <em>C. neoformans</em> in cases of cryptococcosis vary according to geographic location and whether the patient has HIV infection as a predisposing condition [<a href="#rid18">18-21</a>]. An extensive review of 725 clinical isolates of <em>C. neoformans </em>obtained from around the world prior to the AIDS epidemic found that <em>C. neoformans </em>var <em>grubii </em>and <em>C. neoformans </em>var <em>neoformans </em>accounted for 80 percent of isolates [<a href="#rid18">18</a>]. The majority of cryptococcal isolates from patients with AIDS have been <em>C. neoformans </em>var <em>grubii</em> but, in certain locales, <em>C. gattii</em> infections have also been observed in patients with HIV. (See  <a class="medical medical_review" href="/d/html/16624.html" rel="external">"Cryptococcus gattii infection: Microbiology, epidemiology, and pathogenesis", section on 'Hosts'</a>.)</p><p><em>C. neoformans</em> var <em>grubii</em> and var <em>neoformans</em> have been found in soil samples from around the world in areas frequented by birds, especially pigeons and chickens [<a href="#rid22">22</a>]. This fungus has also been isolated from roosting sites of pigeons and in association with rotting vegetation [<a href="#rid23">23</a>].</p><p>The basis for the association of pigeons with <em>C. neoformans</em> var <em>neoformans</em> is uncertain. Pigeons do not become infected with <em>C. neoformans</em> in nature. The organism is probably inhibited within pigeons by their elevated body temperature (over 40°C). Pigeons can, however, harbor the yeast as saprophytes in their gastrointestinal tract.</p><p>The role of pigeon guano in the transmission and pathogenesis of human infections is obscure. A history of intense pigeon exposure is only rarely elicited from patients with cryptococcosis. In addition, outbreaks of the disease have never been traced to pigeon roosting areas. It is possible that pigeons come into contact with <em>C. neoformans</em> var <em>grubii</em> and var <em>neoformans</em> by eating contaminated vegetation. Human infection may result from a similar exposure to contaminated vegetation. One case has been documented of transmission of <em>C. neoformans </em>from a pet cockatoo to a renal transplant recipient who developed cryptococcal meningitis [<a href="#rid24">24</a>]. </p><p>Spread of infection from person to person has not been documented except with transplanted tissue [<a href="#rid25">25</a>]. Interestingly, cryptococcosis is very uncommon in children, even those with AIDS. The reason for the reduced incidence in children is not known.</p><p>Additional discussions of the epidemiology of <em>C. neoformans</em> in patient with and without HIV infection are found is separate topic reviews. (See  <a class="medical medical_review" href="/d/html/3757.html" rel="external">"Epidemiology, clinical manifestations, and diagnosis of Cryptococcus neoformans meningoencephalitis in patients with HIV"</a> and  <a class="medical medical_review" href="/d/html/2447.html" rel="external">"Clinical manifestations and diagnosis of Cryptococcus neoformans meningoencephalitis in patients without HIV"</a>.)</p><p class="headingAnchor" id="H14"><span class="h1">SUMMARY</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Introduction </strong>–<strong> </strong>Cryptococcosis is an invasive fungal infection due to <em>Cryptococcus neoformans </em>or <em>Cryptococcus gattii</em>. <em>C. neoformans</em> is the principal pathogenic member of the genus and has a worldwide distribution. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Taxonomy </strong>–<strong> </strong><em>C. neoformans</em> is a basidiomycetous, encapsulated yeast<em> </em>that<em> </em>can be subclassified in two varieties, var <em>grubii</em> and var <em>neoformans</em>. These organisms are found in soil samples from around the world, in areas frequented by birds, especially pigeons and chickens. (See <a class="local">'Taxonomy'</a> above and <a class="local">'Epidemiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Life cycle </strong>–<strong> </strong>The life cycle of <em>C. neoformans</em> involves asexual and sexual forms. The asexual forms exist as yeasts and reproduce by budding. These haploid, unicellular yeasts are the only forms of <em>C. neoformans</em> that have been recovered from human infections. (See <a class="local">'Life cycle'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Epidemiology </strong>–<strong> </strong>The vast majority of patients with cryptococcosis are immunocompromised. The serotypes or genotypes of <em>C. neoformans</em> in cases of cryptococcosis vary according to geographic location. (See <a class="local">'Epidemiology'</a> above.)</p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Kwon-Chung KJ, Bennett JE, Wickes BL, et al. The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis. mSphere 2017; 2.</a></li><li><a class="nounderline abstract_t">Hagen F, Khayhan K, Theelen B, et al. Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex. Fungal Genet Biol 2015; 78:16.</a></li><li><a class="nounderline abstract_t">Farrer RA, Chang M, Davis MJ, et al. A New Lineage of Cryptococcus gattii (VGV) Discovered in the Central Zambezian Miombo Woodlands. mBio 2019; 10.</a></li><li><a class="nounderline abstract_t">Saul N, Krockenberger M, Carter D. Evidence of recombination in mixed-mating-type and alpha-only populations of Cryptococcus gattii sourced from single eucalyptus tree hollows. Eukaryot Cell 2008; 7:727.</a></li><li><a class="nounderline abstract_t">Firacative C, Trilles L, Meyer W. MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex. PLoS One 2012; 7:e37566.</a></li><li><a class="nounderline abstract_t">Siqueira LPM, Gimenes VMF, de Freitas RS, et al. Evaluation of Vitek MS for Differentiation of Cryptococcus neoformans and Cryptococcus gattii Genotypes. J Clin Microbiol 2019; 57.</a></li><li><a class="nounderline abstract_t">Posteraro B, Efremov L, Leoncini E, et al. Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy. J Clin Microbiol 2015; 53:2439.</a></li><li><a class="nounderline abstract_t">Eisenman HC, Casadevall A, McClelland EE. New insights on the pathogenesis of invasive Cryptococcus neoformans infection. Curr Infect Dis Rep 2007; 9:457.</a></li><li><a class="nounderline abstract_t">Kozel TR, Gotschlich EC. The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages. J Immunol 1982; 129:1675.</a></li><li><a class="nounderline abstract_t">Chang YC, Penoyer LA, Kwon-Chung KJ. The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence. Infect Immun 1996; 64:1977.</a></li><li><a class="nounderline abstract_t">Fries BC, Taborda CP, Serfass E, Casadevall A. Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection. J Clin Invest 2001; 108:1639.</a></li><li><a class="nounderline abstract_t">Salas SD, Bennett JE, Kwon-Chung KJ, et al. Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans. J Exp Med 1996; 184:377.</a></li><li><a class="nounderline abstract_t">Kwon-Chung KJ, Rhodes JC. Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans. Infect Immun 1986; 51:218.</a></li><li><a class="nounderline abstract_t">Polacheck I, Platt Y, Aronovitch J. Catecholamines and virulence of Cryptococcus neoformans. Infect Immun 1990; 58:2919.</a></li><li><a class="nounderline abstract_t">Wang Y, Aisen P, Casadevall A. Cryptococcus neoformans melanin and virulence: mechanism of action. Infect Immun 1995; 63:3131.</a></li><li><a class="nounderline abstract_t">Spec A, Raval K, Powderly WG. End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis. Open Forum Infect Dis 2016; 3:ofv197.</a></li><li><a class="nounderline abstract_t">Bernard C, Maucort-Boulch D, Varron L, et al. Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases. QJM 2013; 106:523.</a></li><li><a class="nounderline abstract_t">Kwon-Chung KJ, Bennett JE. Epidemiologic differences between the two varieties of Cryptococcus neoformans. Am J Epidemiol 1984; 120:123.</a></li><li><a class="nounderline abstract_t">Gerstein AC, Jackson KM, McDonald TR, et al. Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection. mBio 2019; 10.</a></li><li><a class="nounderline abstract_t">Thanh LT, Toffaletti DL, Tenor JL, et al. Assessing the virulence of Cryptococcus neoformans causing meningitis in HIV infected and uninfected patients in Vietnam. Med Mycol 2020; 58:1149.</a></li><li><a class="nounderline abstract_t">Altamirano S, Jackson KM, Nielsen K. The interplay of phenotype and genotype in Cryptococcus neoformans disease. Biosci Rep 2020; 40.</a></li><li><a class="nounderline abstract_t">EMMONS CW. Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia). Am J Hyg 1955; 62:227.</a></li><li><a class="nounderline abstract_t">Lazéra MS, Pires FD, Camillo-Coura L, et al. Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees. J Med Vet Mycol 1996; 34:127.</a></li><li><a class="nounderline abstract_t">Nosanchuk JD, Shoham S, Fries BC, et al. Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient. Ann Intern Med 2000; 132:205.</a></li><li><a class="nounderline abstract_t">Baddley JW, Schain DC, Gupte AA, et al. Transmission of Cryptococcus neoformans by Organ Transplantation. Clin Infect Dis 2011; 52:e94.</a></li></ol></div><div id="topicVersionRevision">Topic 2448 Version 32.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28101535" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : The Case for Adopting the "Species Complex" Nomenclature for the Etiologic Agents of Cryptococcosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25721988" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Recognition of seven species in the Cryptococcus gattii/Cryptococcus neoformans species complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31719178" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : A New Lineage of Cryptococcus gattii (VGV) Discovered in the Central Zambezian Miombo Woodlands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18281600" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Evidence of recombination in mixed-mating-type and alpha-only populations of Cryptococcus gattii sourced from single eucalyptus tree hollows.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22666368" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : MALDI-TOF MS enables the rapid identification of the major molecular types within the Cryptococcus neoformans/C. gattii species complex.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30429250" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Evaluation of Vitek MS for Differentiation of Cryptococcus neoformans and Cryptococcus gattii Genotypes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25994160" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Are the Conventional Commercial Yeast Identification Methods Still Helpful in the Era of New Clinical Microbiology Diagnostics? A Meta-Analysis of Their Accuracy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17999881" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : New insights on the pathogenesis of invasive Cryptococcus neoformans infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7050244" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The capsule of cryptococcus neoformans passively inhibits phagocytosis of the yeast by macrophages.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8675296" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : The second capsule gene of cryptococcus neoformans, CAP64, is essential for virulence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11733559" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Phenotypic switching of Cryptococcus neoformans occurs in vivo and influences the outcome of infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8760791" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Effect of the laccase gene CNLAC1, on virulence of Cryptococcus neoformans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3079732" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Encapsulation and melanin formation as indicators of virulence in Cryptococcus neoformans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2117574" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Catecholamines and virulence of Cryptococcus neoformans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7622240" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Cryptococcus neoformans melanin and virulence: mechanism of action.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26835475" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : End-Stage Liver Disease Is a Strong Predictor of Early Mortality in Cryptococcosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23515400" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6377880" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Epidemiologic differences between the two varieties of Cryptococcus neoformans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31311883" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Identification of Pathogen Genomic Differences That Impact Human Immune Response and Disease during Cryptococcus neoformans Infection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32196550" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Assessing the virulence of Cryptococcus neoformans causing meningitis in HIV infected and uninfected patients in Vietnam.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33021310" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : The interplay of phenotype and genotype in Cryptococcus neoformans disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13268414" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Saprophytic sources of Cryptococcus neoformans associated with the pigeon (Columba livia).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8732358" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Natural habitat of Cryptococcus neoformans var. neoformans in decaying wood forming hollows in living trees.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10651601" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Evidence of zoonotic transmission of Cryptococcus neoformans from a pet cockatoo to an immunocompromised patient.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21220771" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Transmission of Cryptococcus neoformans by Organ Transplantation.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
